81.16
+0.33%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About LeMaitre Vascular
From its filings with the US Securities and Exchange Commission
LeMaitre Vascular is based in Burlington, Massachusetts. Its shares trade on Nasdaq under the ticker LMAT. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $249.6m and net income of $57.7m. At that date it held total assets of $615.7m and shareholders' equity of $393.5m. By region, Americas [Member] accounted for 64.0%, followed by EMEA [Member] at 29.3% and Asia Pacific [Member] at 6.7%.
We are a global provider of medical devices and human tissue cryopreservation services largely used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Our diversified portfolio of devices consists of brand name products that are used in arteries and veins and are well known to vascular surgeons. Our principal product offerings are sold globally, primarily in the United States, Europe, Canada and Asia Pacific. We estimate that the annual worldwide market for peripheral vascular devices exceeds $9 billion, within which we estimate that the market for our products is approximately $1 billion.
We sell our products and services primarily through a direct sales force. Our worldwide headquarters is located in Burlington, Massachusetts, and we also have a North American sales office in Vaughan, Canada. Our European headquarters is located in Sulzbach, Germany, and we also have European sales offices in Milan, Italy; Madrid, Spain; Hereford, England; Dublin, Ireland; Maisons-Alfort, France; and Glattbrugg, Switzerland. Our Asia Pacific headquarters is located in Singapore, and we also have Asia Pacific sales offices in Tokyo, Japan; Shanghai, China; Docklands, Australia; Seoul, Korea; and Bangkok, Thailand.
Quoted from its 10-K, filed 26 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 19 Oct 2006
- Employees
- 646
- Website
- lemaitre.com ↗
- Head office
- 63 SECOND AVENUE, BURLINGTON, MA, 01803
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. George LemaitreChairman of the Board, Chief Executive Officer, since 1992$3.2m
- Mr. David RobertsPresident, Director, since 1997$1.1m
- Mr. Dorian LeBlancChief Financial Officer
- Mr. Maik HelmersSenior Vice President - Sales, Central Europe
- Mr. Ryan ConnellySenior Vice President - Advanced Manufacturing Engineering
- Mr. Andrew HodgkinsonSenior Vice President - Clinical, Regulatory, Quality Affairs
- Mr. Trent KamkeSenior Vice President - Operations$869,704
- Mr. Stephane MaierSenior Vice President, Operations - EMEA
- Mr. Jonathan NgauSenior Vice President - Information Technology
- Mr. Jacob PetersenSenior Vice President, International
- Mr. Christopher MinnettVice President Sales and Marketing, Americas
- Ms. Giovannella DeiureVice President - Sales, Southern Europe
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 27
- Environment
- 7
- Social
- 41
- Governance
- 35
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- LeMaitre Vascular Inc boasts a highly experienced and skilled management team capable of executing strategic decisions effectively. The company's established brand reputation and strong market presence provide a competitive advantage, allowing for easier market penetration and customer acquisition. LeMaitre Vascular also benefits from a diverse product portfolio, offering a wide range of innovative medical devices and solutions.
Weaknesses
- One weakness of LeMaitre Vascular is its overdependence on specific product lines, potentially exposing the company to market fluctuations and unforeseen disruptions. Additionally, the company's limited distribution network in certain regions may hinder its expansion capabilities. Improved diversification and wider market coverage are areas that require attention.
Opportunities
- The growing demand for minimally invasive medical procedures presents a significant opportunity for LeMaitre Vascular. By developing and promoting advanced technologies and solutions in this space, the company can tap into a burgeoning market segment. Furthermore, expanding its presence in untapped markets and forming strategic partnerships with healthcare centers and professionals can lead to increased revenue and market share.
Threats
- LeMaitre Vascular operates in an industry characterized by intense competition and rapid technological advancements. This poses a threat to the company's market position, as competitors may introduce innovative products or engage in aggressive pricing strategies. Additionally, regulatory changes and uncertainties within the healthcare industry can disrupt business operations and impact revenue. Adopting proactive measures to stay ahead of market changes and conforming to evolving regulations is vital.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.